CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
65.55
-1.27 (-1.90%)
At close: Apr 28, 2026, 4:00 PM EDT
66.85
+1.30 (1.98%)
After-hours: Apr 28, 2026, 7:47 PM EDT
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.53 billion as of April 28, 2026. Its market cap has increased by 311.90% in one year.
Market Cap
5.53B
Enterprise Value
4.80B
1-Year Change
311.90%
Ranking
Category
Stock Price
$65.55
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.53B, an increase of 358.87%. That is a compound annual growth rate of 96.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.64B | 68.45% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 6.17B |
| Spyre Therapeutics | 6.16B |
| Centessa Pharmaceuticals | 6.12B |
| Terns Pharmaceuticals | 6.11B |
| Celcuity | 6.08B |
| Cogent Biosciences | 5.93B |
| Rhythm Pharmaceuticals | 5.93B |
| Immunovant | 5.90B |